[Bridge role of Jingming (BL 1) for VDT asthenopia and brainfag based on human instinct]
- PMID: 29231331
- DOI: 10.13703/j.0255-2930.2017.01.022
[Bridge role of Jingming (BL 1) for VDT asthenopia and brainfag based on human instinct]
Abstract
To explore the bridge role of Jingming (BL 1) for video display terminal (VDT) asthenopia and brainfag. Ancient literature and modern scientific research on the acupoint have been analyzed and summarized so as to explore pressing the acupoint the instinct feedback of brain after asthenopia. It is demonstrated that Jingming (BL 1) is a key channel between eyes, brain and the outside world, and it is one of major feedback points of brain after asthenopia. In this paper we try to establish a new research thinking and ascertain it, namely Jingming (BL 1) reflecting the relationship between asthenopia and brainfag. We hope that it can provide some references for further research on cognizing brain through eye.
Keywords: Point BL 1 (Jingming); asthenopia; brainfag; video display terminal (VDT).
Similar articles
-
[Efficacy evaluation of acupoints massage on asthenopia of video display terminal under different exposure dose].Zhongguo Zhen Jiu. 2012 Apr;32(4):351-3. Zhongguo Zhen Jiu. 2012. PMID: 22734390 Clinical Trial. Chinese.
-
[Take high of the study of VDT related eye symptoms].Zhonghua Yan Ke Za Zhi. 2005 Nov;41(11):963-5. Zhonghua Yan Ke Za Zhi. 2005. PMID: 16318743 Chinese.
-
[Visual fatigue in video display terminal users in relation to the type of displayed information].Gig Sanit. 2010 Mar-Apr;(2):57-60. Gig Sanit. 2010. PMID: 20491271 Russian.
-
Is computer use a risk factor for myopia?J Am Optom Assoc. 1996 Sep;67(9):521-30. J Am Optom Assoc. 1996. PMID: 8888885 Review.
-
Eye problems and visual display terminals--the facts and the fallacies.Ophthalmic Physiol Opt. 1998 Mar;18(2):111-9. Ophthalmic Physiol Opt. 1998. PMID: 9692030 Review.
Cited by
-
Effectiveness of acupuncture at acupoint BL1 (Jingming) in comparison with artificial tears for moderate to severe dry eye disease: a randomized controlled trial.Trials. 2022 Jul 27;23(1):605. doi: 10.1186/s13063-022-06486-4. Trials. 2022. PMID: 35897025 Free PMC article. Clinical Trial.